NCT01184001 - A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Treatment A

Single dose of tasocitinib (CP-690,550) 10 mg under fed conditions.

DRUG

Treatment B

Single dose of tasocitinib (CP-690,550) 10 mg under fasted conditions.

DRUG

Treatment B

Single dose of tasocitinib (CP-690,550) 10 mg under fasted conditions.

DRUG

Treatment A

Single dose of tasocitinib (CP-690,550) 10 mg under fed conditions.

Trial Locations (1)

Pfizer Investigational Site, Singapore